title: Sentinel node and mechanism of lymphatic metastasis.
abstract: The validity and clinical usefulness of the sentinel node (SN) concept for breast cancer has been confirmed, and individualized limited surgery based on diagnosis of SN metastasis is presently performed. In the future, SN navigation surgery (SNNS) will be actively applied to the treatment of early gastric cancer, and an intraoperative real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to detect SN micrometastasis of gastric cancer is under development. Not only anatomical factors, but also many other factors such as local immunosuppression in the SN and lymphoangiogenesis may be involved in development of SN micrometastasis, and clarification of the mechanisms of metastasis and development of treatment methods are awaited. (*English Translation of J Jpn Col Angiol 2008; 48: 137-142.).
authors.affiliation: Department of Surgery, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan.
authors.forename: Hiroya
authors.initials: H
authors.lastname: Takeuchi
authors.forename: Yuko
authors.initials: Y
authors.lastname: Kitagawa
keywords: RT-PCR; chemokine; lymphoangiogenesis; micrometastasis; sentinel node
references.citation: JAMA. 2011 Feb 9;305(6):569-75
references.pmid: 21304082
references.citation: Clin Cancer Res. 2005 Jan 1;11(1):107-12
references.pmid: 15671534
references.citation: Cancer Res. 2002 Mar 1;62(5):1315-20
references.pmid: 11888898
references.citation: Cancer Immunol Immunother. 2011 May;60(5):685-92
references.pmid: 21327637
references.citation: J Exp Med. 2005 Apr 4;201(7):1089-99
references.pmid: 15809353
references.citation: Cell. 1999 Sep 17;98(6):769-78
references.pmid: 10499794
references.citation: Science. 2002 Jun 7;296(5574):1883-6
references.pmid: 11976409
references.citation: Cancer Res. 2006 Mar 1;66(5):2650-7
references.pmid: 16510584
references.citation: Biochim Biophys Acta. 2012 Jan;1825(1):117-29
references.pmid: 22079531
references.citation: Nat Med. 2001 Feb;7(2):192-8
references.pmid: 11175850
references.citation: EMBO J. 1996 Jan 15;15(2):290-98
references.pmid: 8617204
references.citation: Nat Med. 2001 Feb;7(2):186-91
references.pmid: 11175849
references.citation: Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13513-8
references.pmid: 14595012
references.citation: Ann Surg Oncol. 2012 Feb;19(2):469-77
references.pmid: 22065193
references.citation: Cancer Res. 2001 Mar 1;61(5):1786-90
references.pmid: 11280723
references.citation: Lancet. 1997 Jun 28;349(9069):1864-7
references.pmid: 9217757
references.citation: J Exp Med. 2002 Aug 19;196(4):417-30
references.pmid: 12186835
references.citation: Surg Clin North Am. 2000 Dec;80(6):1799-809
references.pmid: 11140874
references.citation: Cancer Treat Res. 2005;127:123-39
references.pmid: 16209080
references.citation: Cancer Res. 2005 Nov 1;65(21):9789-98
references.pmid: 16267000
references.citation: Clin Cancer Res. 2007 Jun 1;13(11):3125-32
references.pmid: 17545514
references.citation: J Clin Oncol. 2009 Oct 1;27(28):4679-84
references.pmid: 19720928
references.citation: Immunity. 2000 Feb;12(2):121-7
references.pmid: 10714678
references.citation: Br J Cancer. 2007 Jun 18;96(12):1879-87
references.pmid: 17565341
references.citation: Cancer Res. 1987 Mar 15;47(6):1740-4
references.pmid: 3493068
references.citation: Clin Cancer Res. 2004 Apr 1;10(7):2351-8
references.pmid: 15073111
references.citation: Int Immunol. 1998 Jul;10(7):901-10
references.pmid: 9701028
references.citation: Ann Surg Oncol. 2004 Mar;11(3 Suppl):250S-4S
references.pmid: 15023762
references.citation: J Immunol. 1998 Sep 15;161(6):3096-102
references.pmid: 9743376
references.citation: Clin Cancer Res. 2004 Oct 15;10(20):6912-8
references.pmid: 15501969
references.citation: Arch Surg. 1992 Apr;127(4):392-9
references.pmid: 1558490
references.citation: J Leukoc Biol. 2006 Oct;80(4):691-6
references.pmid: 16793912
references.citation: Ann Surg. 1994 Sep;220(3):391-8; discussion 398-401
references.pmid: 8092905
references.citation: J Cell Biol. 1999 Feb 22;144(4):789-801
references.pmid: 10037799
references.citation: World J Surg. 2011 Nov;35(11):2463-71
references.pmid: 21882026
references.citation: Cancer Res. 2005 Mar 1;65(5):1800-7
references.pmid: 15753377
references.citation: Cancer Sci. 2008 Mar;99(3):441-50
references.pmid: 18070155
references.citation: Blood. 2005 Nov 15;106(10):3423-31
references.pmid: 16076871
references.citation: EMBO J. 2001 Feb 15;20(4):672-82
references.pmid: 11179212
references.citation: Melanoma Res. 2005 Apr;15(2):99-106
references.pmid: 15846142
references.citation: Am J Pathol. 1999 Feb;154(2):385-94
references.pmid: 10027397
references.citation: Proc Natl Acad Sci U S A. 1998 Jan 6;95(1):258-63
references.pmid: 9419363
references.citation: Blood. 2002 Mar 15;99(6):2179-84
references.pmid: 11877295
references.citation: Clin Cancer Res. 2006 Dec 1;12(23):6865-8
references.pmid: 17145802
references.citation: J Pathol. 2012 Jan;226(2):148-57
references.pmid: 21989643
references.citation: Int J Cancer. 2002 Apr 20;98(6):946-51
references.pmid: 11948478
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: Cancer. 2003 Jul 15;98(2):413-23
references.pmid: 12872364
references.citation: Ann Surg Oncol. 2012 May;19(5):1541-50
references.pmid: 22048632
references.citation: Cancer Res. 2004 Nov 15;64(22):8239-48
references.pmid: 15548690
references.citation: Ann Surg. 1994 Dec;220(6):759-67
references.pmid: 7986143
references.citation: World J Surg. 2006 Nov;30(11):1962-8
references.pmid: 17043938
references.citation: Ann Surg. 2006 Mar;243(3):341-7
references.pmid: 16495698
references.citation: Cell. 1998 Mar 20;92(6):735-45
references.pmid: 9529250
references.citation: Nat Rev Immunol. 2006 Sep;6(9):659-70
references.pmid: 16932751